27381582|t|Antidiabetic potential of bioactive molecules coated chitosan nanoparticles in experimental rats
27381582|a|The present study was carried out to examine the antidiabetic effects of chitosan nanoparticles (CNPs) loaded with (Stevia rebaudiana leaf extract - SRLE) bioactive molecules in a rat model of streptozotocin (STZ) induced diabetes mellitus. Successful crosslinking of the bioactive molecules to the chitosan nanoparticles was confirmed by Fourier Transform Infrared Spectroscopy (FTIR). The colloidal characteristics of the synthesized nanoparticles were revealed by X-ray Diffraction (XRD) analysis. Morphological analysis by Transmission Electron Microscopy (TEM) revealed that the bioactive molecule -loaded CNPs were well-dispersed and spherical or polygonal in shape with an average size of<73.27nm than the z-average value (327nm) as measured by Dynamic Light Scattering (DLS). SRLE CNP - treated diabetic rats showed a significant reduction in their mean fasting blood glucose level compared with the diabetic control group. The serum levels of various enzymes viz., serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), alkaline phosphatases (ALP), lipid peroxidation, and antioxidant such as catalase (CAT), reduced glutathione (GSH), and superoxide dismutase (SOD) in the SRLE CNP - treated group were closer to normal levels than those in the diabetic control group.
27381582	0	12	Antidiabetic	T121	C0935929
27381582	13	22	potential	T080	C3245505
27381582	26	45	bioactive molecules	T167	C3714412
27381582	53	75	chitosan nanoparticles	T109,T121	C0162969
27381582	79	91	experimental	T080	C1517586
27381582	92	96	rats	T015	C0034721
27381582	109	114	study	T062	C2603343
27381582	146	158	antidiabetic	T121	C0935929
27381582	159	169	effects of	T080	C1704420
27381582	170	192	chitosan nanoparticles	T109,T121	C0162969
27381582	194	198	CNPs	T109,T121	C0162969
27381582	213	243	Stevia rebaudiana leaf extract	T109,T121	C3267306
27381582	246	250	SRLE	T109,T121	C3267306
27381582	252	271	bioactive molecules	T167	C3714412
27381582	277	280	rat	T015	C0034721
27381582	281	286	model	T050	C0012644
27381582	290	304	streptozotocin	T109,T195	C0038432
27381582	306	309	STZ	T109,T195	C0038432
27381582	311	318	induced	T169	C0205263
27381582	319	336	diabetes mellitus	T050	C0011853
27381582	349	361	crosslinking	T070	C0178576
27381582	369	388	bioactive molecules	T167	C3714412
27381582	396	418	chitosan nanoparticles	T109,T121	C0162969
27381582	436	475	Fourier Transform Infrared Spectroscopy	T062	C0206055
27381582	477	481	FTIR	T062	C0206055
27381582	488	513	colloidal characteristics	T080	C1521970
27381582	521	532	synthesized	T052	C1883254
27381582	533	546	nanoparticles	T109,T121	C0162969
27381582	564	596	X-ray Diffraction (XRD) analysis	T059	C0599643
27381582	598	611	Morphological	T082	C0543482
27381582	612	620	analysis	T062	C0936012
27381582	624	656	Transmission Electron Microscopy	T059	C0678118
27381582	658	661	TEM	T059	C0678118
27381582	681	699	bioactive molecule	T167	C3714412
27381582	708	712	CNPs	T109,T121	C0162969
27381582	718	732	well-dispersed	T080	C0205556
27381582	737	746	spherical	T082	C0332501
27381582	750	759	polygonal	T082	C2347622
27381582	763	768	shape	T082	C0332479
27381582	777	789	average size	T082	C0456389
27381582	810	825	z-average value	T081	C1883591
27381582	849	873	Dynamic Light Scattering	T059	C1882368
27381582	875	878	DLS	T059	C1882368
27381582	881	885	SRLE	T109,T121	C3267306
27381582	886	889	CNP	T109,T121	C0162969
27381582	892	899	treated	T169	C1522326
27381582	900	908	diabetic	T050	C0011853
27381582	909	913	rats	T015	C0034721
27381582	923	934	significant	T078	C0750502
27381582	935	944	reduction	T081	C0547047
27381582	959	986	fasting blood glucose level	T034	C1261430
27381582	1005	1013	diabetic	T050	C0011853
27381582	1014	1027	control group	T096	C0009932
27381582	1033	1038	serum	T031	C0229671
27381582	1039	1045	levels	T080	C0441889
27381582	1057	1064	enzymes	T116,T126	C0014442
27381582	1071	1110	serum glutamic oxaloacetic transaminase	T116,T126	C0242192
27381582	1112	1116	SGOT	T116,T126	C0242192
27381582	1119	1154	serum glutamic pyruvic transaminase	T116,T126	C0376147
27381582	1156	1160	SGPT	T116,T126	C0376147
27381582	1163	1184	alkaline phosphatases	T116,T126	C0002059
27381582	1186	1189	ALP	T116,T126	C0002059
27381582	1192	1210	lipid peroxidation	T044	C0023775
27381582	1216	1227	antioxidant	T121	C0003402
27381582	1236	1244	catalase	T116,T126	C0007367
27381582	1246	1249	CAT	T116,T126	C0007367
27381582	1252	1271	reduced glutathione	T034	C0034917
27381582	1273	1276	GSH	T034	C0034917
27381582	1283	1303	superoxide dismutase	T116,T121,T126	C0038838
27381582	1305	1308	SOD	T116,T121,T126	C0038838
27381582	1317	1321	SRLE	T109,T121	C3267306
27381582	1322	1325	CNP	T109,T121	C0162969
27381582	1328	1335	treated	T169	C1522326
27381582	1336	1341	group	T078	C0441833
27381582	1357	1363	normal	T080	C0205307
27381582	1364	1370	levels	T080	C0441889
27381582	1389	1397	diabetic	T050	C0011853
27381582	1398	1411	control group	T096	C0009932